• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    RXO Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/23/25 4:10:28 PM ET
    $RXO
    Transportation Services
    Consumer Discretionary
    Get the next $RXO alert in real time by email
    rxo-20250521
    0001929561FALSE00019295612025-05-212025-05-21

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): May 21, 2025
     
    RXO, INC.
    (Exact name of registrant as specified in its charter)
    Delaware
    001-4151488-2183384
    (State or other jurisdiction of
    incorporation)
    (Commission File Number)
    (IRS Employer
    Identification No.)
     
    11215 North Community House Road28277
    Charlotte, NC
    (Address of principal executive offices)(Zip Code)
     
    (980) 308-6058
    (Registrant’s telephone number, including area code)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class Trading
    symbol(s)
     
    Name of each exchange on which
    registered
    Common stock, par value $0.01 per share
     RXO New York Stock Exchange
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     




    Item 5.07    Submission of Matters to a Vote of Security Holders.
    RXO, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) on May 21, 2025. The following matters, which are described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 2, 2025 (the “Proxy Statement”), were voted upon by the Company’s stockholders at the Annual Meeting. The final voting results are below:
    Proposal 1 – Election of Directors.
    Each of the following individuals were elected by the stockholders to serve as Class II directors and Class III directors of the Company for a term expiring at the annual meeting of stockholders in 2026 and until their respective successors have been elected and qualified or until their death, resignation or removal, based upon the votes set forth in the table below:
    Class II Directors
    Name of Nominee
    For
    Against
    Abstain
    Broker
    Non-Votes
    Christine Breves
    144,711,332
    363,505
    57,314
    7,208,743
    Troy Cooper
    144,961,176
    148,210
    22,765
    7,208,743
    Adrian Kingshott
    144,204,007
    892,020
    36,124
    7,208,743
    Class III Directors
    Name of Nominee
    For
    Against
    Abstain
    Broker
    Non-Votes
    Mary Kissel
    144,641,203
    455,255
    35,693
    7,208,743
    Michelle Nettles
    144,389,119
    707,636
    35,396
    7,208,743
    Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm.
    The Company’s stockholders ratified the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2025 based upon the votes set forth in the table below:
    For
    Against
    Abstain
    152,184,572
    124,312
    32,010
    Proposal 3 – Advisory Vote to Approve Executive Compensation.
    The Company’s stockholders approved a nonbinding, advisory resolution approving the compensation of the Company’s named executive officers, as set forth in the Proxy Statement, based upon the votes set forth in the table below:
    For
    Against
    Abstain
    Broker Non-Votes
    139,565,395
    5,490,043
    76,713
    7,208,743



    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

     
    Date: May 23, 2025
    RXO, INC. 
     
    By:/s/ Jeffrey D. Firestone 
    Jeffrey D. Firestone 
    Chief Legal Officer and Corporate Secretary 
     
     
     

    Get the next $RXO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RXO

    DatePrice TargetRatingAnalyst
    4/4/2025Outperform → Perform
    Oppenheimer
    3/13/2025$24.00Buy
    Truist
    3/7/2025$19.00Hold
    Deutsche Bank
    11/18/2024$29.00Neutral
    Goldman
    11/12/2024$33.00Buy → Neutral
    Citigroup
    11/11/2024$31.00Equal Weight
    Wells Fargo
    10/9/2024$33.00Buy
    Citigroup
    5/15/2024Mkt Perform
    Raymond James
    More analyst ratings